Liquid Dosage

Antibiotics

Antibiotics, compounds or substances that combat bacterial infections and kill or slow down their growth, comprise one of the most important groups of drugs in the fight against infectious diseases. Representing around 13% of total pharmaceutical consumption, they have the highest market share of any pharmaceutical product.

In liquid-based applications, the pharmaceutical industry extracts antibiotics from fermentation broths. GEA supports this process with special decanters that facilitate the process, offering efficient direct extraction solutions that are also environmentally friendly.

The Extraction Process

Extraction essentially consists of two combined processes: mixing and separating. GEA has developed a patented decanter that combines the two process steps in a single machine to enhance the extraction of active ingredients.

This decanter allows suspensions with a high solids content to be processed, rendering them suitable for direct antibiotic extraction from the culture solution (which often has a high mycelium content). The previously essential filtration step is no longer required, which not only makes the process continuous, it also prevents the loss of valuable material that was frequently associated with filtration.

Advantages of Direct Extraction

Offering increased total yields of up to 98% compared with conventional counter-current extraction, direct extraction is also significantly more cost-effective (no filter aids are needed). The fermentation broth itself is not diluted by filter wash water, which both reduces the solvent requirement and the risk of infection. In addition, the optimized procedure also reduces wastewater pollution and the actual volume of wastewater produced.

The GEA Solution

Driven by new product innovations, high levels of R&D investment and the pharmaceutical industry’s need to ameliorate the issue of antibiotic resistance, the antibiotic market is expected to show continued growth. From R&D-scale and standalone manufacturing equipment to completely integrated process lines that maximize operational reliability, GEA supplies a complete range of equipment and solutions for the industrial-scale production of antibiotics, antibacterials and anti-infectives.

Downloads

GEA Insights

GEA misison 30 logo

A strategy for the better: CEO interview on GEA's Mission 30

After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.

Blu-Red software accelerates climate-friendly energy tech

Program Blu-Red przyspiesza rozwój przyjaznych dla klimatu technologii energetycznych

Podczas gdy coraz więcej społeczności i firm polega na instalacjach pomp ciepła oraz ekologicznej technologii chłodzenia, zapewnienie stabilnego działania tych systemów odgrywa newralgiczną rolę. Oprogramowanie zarządzające GEA...

Shaping the future of sustainable wood fiber insulation production

Kształtujemy przyszłość opartej na zrównoważonym rozwoju produkcji izolacji z włókien drzewnych

Lignatherm AG, firma dążąca do przywrócenia potencjału produkcyjnego szwajcarskich drewnopochodnych płyt izolacyjnych, liczy na innowacyjny i trzystopniowy system uzdatniania wody od GEA, pozwalający odzyskać niemal 100% wody...

Otrzymuj wiadomości od GEA

Śledź innowacje i historie GEA, zarejestruj się do biuletynu z wiadomościami od GEA.

Skontaktuj się z nami

Jesteśmy po to, by Ci pomóc! Potrzebujemy kilku informacji, by odpowiedzieć na Twoje zapytanie.